USUna Smailovic

Una Smailovic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Una Smailovic has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Vesna Jelic

    Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden

    6 shared publications
  • Bengt Winblad

    Division of Neurogeriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden

    5 shared publications
  • Thomas Andersson

    Department of Clinical Neurophysiology, Karolinska University Hospital, Huddinge, Sweden

    3 shared publications
  • Thomas Koenig

    Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland

    3 shared publications
  • Thomas Koenig

    Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland

    3 shared publications
  • Ingemar Kåreholt

    Aging Research Centre, Karolinska Institutet and Stockholm University, Stockholm, Sweden; Institute for Gerontology, School of Health and Welfare, Aging Research Network - Jönköping (ARN-J), Jönköping University, Jönköping, Sweden

    2 shared publications

Latest Publications

  • Open Access

    New trends in the research of psychiatric and neurodegenerative diseases: a tribute to Melita Salkovic-Petrisic

    by Jelena Osmanović Barilar, Edna Gruenblat, Angelica Schmidt-Böhrer, Una Smailović, Ismet Tahirović, Goran Šimić, Ana Knezović, Ana Babić Perhoč, Eugenio Barone, Nenad Bogdanović, et al.

  • Open Access

    Decreased Global EEG Synchronization in Amyloid Positive Mild Cognitive Impairment and Alzheimer’s Disease Patients—Relationship to APOE ε4

    by Una Smailovic, Charlotte Johansson, Thomas Koenig, Ingemar Kåreholt, Caroline Graff, Vesna Jelic

    The apolipoprotein E (APOE) ε4 allele is a risk factor for Alzheimer’s disease (AD) that has been linked to changes in brain structure and function as well as to different biological subtypes of the disease. The present study aimed to investigate the association of APOE ε4 genotypes with brain functional impairment, as assessed by quantitative EEG (qEEG) in patients on the AD continuum. The study population included 101 amyloid positive patients diagnosed with mild cognitive impairment (MCI) (n = 50) and AD (n = 51) that underwent resting-state EEG recording and CSF Aβ42 analysis. In total, 31 patients were APOE ε4 non-carriers, 42 were carriers of one, and 28 were carriers of two APOE ε4 alleles. Quantitative EEG analysis included computation of the global field power (GFP) and global field synchronization (GFS) in conventional frequency bands. Amyloid positive patients who were carriers of APOE ε4 allele(s) had significantly higher GFP beta and significantly lower GFS in theta and beta bands compared to APOE ε4 non-carriers. Increased global EEG power in beta band in APOE ε4 carriers may represent a brain functional compensatory mechanism that offsets global EEG slowing in AD patients. Our findings suggest that decreased EEG measures of global synchronization in theta and beta bands reflect brain functional deficits related to the APOE ε4 genotype in patients that are on a biomarker-verified AD continuum.


  • Open Access

    Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism

    by Una Smailovic, Thomas Koenig, Irina Savitcheva, Konstantinos Chiotis, Agneta Nordberg, Kaj Blennow, Bengt Winblad, Vesna Jelic

    Introduction: The disconnection hypothesis of Alzheimer's disease (AD) is supported by growing neuroimaging and neurophysiological evidence of altered brain functional connectivity in cognitively impaired individuals. Brain functional modalities such as [ 18 F]fluorodeoxyglucose positron-emission tomography ([ 18 F]FDG-PET) and electroencephalography (EEG) measure different aspects of synaptic functioning, and can contribute to understanding brain connectivity disruptions in AD. Aim: This study investigated the relationship between cortical glucose metabolism and topographical EEG measures of brain functional connectivity in subjects along AD continuum. Methods: Patients diagnosed with mild cognitive impairment (MCI) and AD ( n = 67), and stratified into amyloid-positive ( n = 32) and negative ( n = 10) groups according to cerebrospinal fluid Aβ42/40 ratio, were assessed with [ 18 F]FDG-PET and resting-state EEG recordings. EEG-based neuroimaging analysis involved standardized low-resolution electromagnetic tomography (sLORETA), which estimates functional connectivity from cortical sources of electrical activity in a 3D head model. Results: Glucose hypometabolism in temporoparietal lobes was significantly associated with altered EEG functional connectivity of the same regions of interest in clinically diagnosed MCI and AD patients and in patients with biomarker-verified AD pathology. The correlative pattern of disrupted connectivity in temporoparietal lobes, as detected by EEG sLORETA analysis, included decreased instantaneous linear connectivity in fast frequencies and increased lagged linear connectivity in slow frequencies in relation to the activity of remaining cortex. Conclusions: Topographical EEG measures of functional connectivity detect regional dysfunction of AD-vulnerable brain areas as evidenced by association and spatial overlap with the cortical glucose hypometabolism in MCI and AD patients. Impact statement: The association between glucose hypometabolism, as evidenced by [ 18 F]FDG-PET ([ 18 F]fluorodeoxyglucose positron-emission tomography), and altered electroencephalography (EEG) functional connectivity metrics within temporoparietal lobes provides link between synaptic, neurophysiological, and metabolic impairment in mild cognitive impairment and Alzheimer's disease patients. This study reported alterations in EEG measures of both instantaneous and lagged linear connectivity across distinct frequency bands, both of which were shown to be important for inter- and intrahemispheric communication and function of memory systems in general. EEG-based imaging of brain functional connectivity has a potential to serve as a noninvasive, low-cost, and widely available alternative in assessing synaptic and network dysfunction in cognitively impaired patients.


  • Translational potential of mouse CSF biomarkers in Alzheimer’s disease: Association of CSF neurogranin with tau, NFL and amyloid pathology in APP knock‐in mouse models

    by Una Smailovic, Ljerka Delac, Victor Liman, Hlin Kvartsberg, Bengt Winblad, Vesna Jelic, Kina Höglund, Henrik Zetterberg, Kaj Blennow, Per Nilsson

    Background: Alzheimer’s disease (AD) is characterized by early and progressive synaptic dysfunction and loss that are closely related to cognitive impairment in AD patients. Neurogranin (Ng) has emerged as a potential marker of synaptic dysfunction, with cerebrospinal fluid (CSF) levels specifically increased in AD. In order to investigate the translational potential of CSF Ng, the present study investigated its alterations and relationship to AD‐related pathology (Aβ42, tau and neurofilament light; NFL) in both CSF and brain tissue of novel App knock‐in mouse models.Methods: CSF and brain tissue were sampled from 12‐months old wild type (WT), AppNL‐F/NL‐F and AppNL‐G‐F/NL‐G‐F mice. CSF and brain (cortex and hippocampus) Ng, Aβ42, t‐tau and NFL protein levels were analyzed using new ultra sensitive digital enzyme‐linked immunosorbent assays on the Simoa platform. Differences in expression of Ng in the brain tissue and its relation to amyloid plaques in App knock‐in mice were investigated by immunohistochemistry (IHC).Results: CSF Ng, t‐tau and NFL levels were significantly increased in App knock‐in compared to WT mice (p < 0.05). CSF Ng negatively correlated with Ng levels in the cortex and Aβ42 levels in the CSF and positively correlated with CSF t‐tau and NFL levels (p < 0.05). Loss of neurogranin in the dendrites of hippocampal CA1 region of App knock‐in mice was closely associated with the localization of Aβ plaques in double IHC stainings.Conclusions: App knock‐in mice exhibit synaptic degeneration that is associated with AD neuropathology and remarkably comparable to findings from clinical studies. CSF Ng is potential translational marker of synaptic degeneration in AD.

  • Open Access

    Corrigendum to Quantitative EEG power and synchronization correlate with Alzheimer's disease CSF biomarkers Neurobiology of Aging 63 (2018) 88-95

    by Una Smailovic, Thomas Koenig, Ingemar Kåreholt, Thomas Andersson, Milica Gregoric Kramberger, Bengt Winblad, Vesna Jelic


  • Open Access

    Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach

    by Una Smailovic, Vesna Jelic

    Currently established and employed biomarkers of Alzheimer's disease (AD) predominantly mirror AD-associated molecular and structural brain changes. While they are necessary for identifying disease-specific neuropathology, they lack a clear and robust relationship with the clinical presentation of dementia; they can be altered in healthy individuals, while they often inadequately mirror the degree of cognitive and functional deficits in affected subjects. There is growing evidence that synaptic loss and dysfunction are early events during the trajectory of AD pathogenesis that best correlate with the clinical symptoms, suggesting measures of brain functional deficits as candidate early markers of AD. Resting-state electroencephalography (EEG) is a widely available and noninvasive diagnostic method that provides direct insight into brain synaptic activity in real time. Quantitative EEG (qEEG) analysis additionally provides information on physiologically meaningful frequency components, dynamic alterations and topography of EEG signal generators, i.e. neuronal signaling. Numerous studies have shown that qEEG measures can detect disruptions in activity, topographical distribution and synchronization of neuronal (synaptic) activity such as generalized EEG slowing, reduced global synchronization and anteriorization of neuronal generators of fast-frequency resting-state EEG activity in patients along the AD continuum. Moreover, qEEG measures appear to correlate well with surrogate markers of AD neuropathology and discriminate between different types of dementia, making them promising low-cost and noninvasive markers of AD. Future large-scale longitudinal clinical studies are needed to elucidate the diagnostic and prognostic potential of qEEG measures as early functional markers of AD on an individual subject level.


  • Open Access

    EEG time signature in Alzheimer´s disease: Functional brain networks falling apart

    by Una Smailovic, Thomas Koenig, Erika J Laukka, Grégoria Kalpouzos, Thomas Andersson, Bengt Winblad, Vesna Jelic


  • Open Access

    Quantitative EEG power and synchronization correlate with Alzheimer's disease CSF biomarkers

    by Una Smailovic, Thomas Koenig, Ingemar Kåreholt, Thomas Andersson, Milica Gregoric Kramberger, Bengt Winblad, Vesna Jelic